Haemonetics (HAE) Other Operating Expenses (2010 - 2026)

Haemonetics' Other Operating Expenses history runs 14 years deep, the most recent figure standing at $85.9 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 832.2% year-over-year to $85.9 million in Q1 2026; TTM through Mar 2026 was $128.7 million, a 365.67% increase from a year earlier, with the FY2026 full-year figure at $128.7 million, changed N/A from the prior year.
• Other Operating Expenses advanced to $85.9 million in Q1 2026 per HAE's latest filing, from $11.6 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $85.9 million in Q1 2026 and bottomed at -$11.7 million in Q1 2025.
• The 5-year median for Other Operating Expenses is $11.6 million (2025), against an average of $15.3 million.
• Across the five-year window, Other Operating Expenses surged 1790.58% in 2023 and slumped 156.26% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at $382000.0 in 2022, then surged by 1709.16% to $6.9 million in 2023, then jumped by 76.96% to $12.2 million in 2024, then declined by 4.75% to $11.6 million in 2025, then soared by 637.04% to $85.9 million in 2026.
• Per Business Quant, the three latest HAE Other Operating Expenses figures stand at $85.9 million (Q1 2026), $11.6 million (Q4 2025), and $19.8 million (Q3 2025).